These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Syncytia formation by SARS-CoV-2-infected cells. Buchrieser J; Dufloo J; Hubert M; Monel B; Planas D; Rajah MM; Planchais C; Porrot F; Guivel-Benhassine F; Van der Werf S; Casartelli N; Mouquet H; Bruel T; Schwartz O EMBO J; 2020 Dec; 39(23):e106267. PubMed ID: 33051876 [TBL] [Abstract][Full Text] [Related]
3. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage. Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586 [TBL] [Abstract][Full Text] [Related]
4. The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation. Rajah MM; Bernier A; Buchrieser J; Schwartz O J Mol Biol; 2022 Mar; 434(6):167280. PubMed ID: 34606831 [TBL] [Abstract][Full Text] [Related]
5. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related]
6. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA Elife; 2021 Aug; 10():. PubMed ID: 34435953 [TBL] [Abstract][Full Text] [Related]
7. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types. Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE Elife; 2021 Feb; 10():. PubMed ID: 33570490 [TBL] [Abstract][Full Text] [Related]
8. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections. Musarrat F; Chouljenko V; Dahal A; Nabi R; Chouljenko T; Jois SD; Kousoulas KG J Med Virol; 2020 Oct; 92(10):2087-2095. PubMed ID: 32374457 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 spike D614G change enhances replication and transmission. Zhou B; Thao TTN; Hoffmann D; Taddeo A; Ebert N; Labroussaa F; Pohlmann A; King J; Steiner S; Kelly JN; Portmann J; Halwe NJ; Ulrich L; Trüeb BS; Fan X; Hoffmann B; Wang L; Thomann L; Lin X; Stalder H; Pozzi B; de Brot S; Jiang N; Cui D; Hossain J; Wilson MM; Keller MW; Stark TJ; Barnes JR; Dijkman R; Jores J; Benarafa C; Wentworth DE; Thiel V; Beer M Nature; 2021 Apr; 592(7852):122-127. PubMed ID: 33636719 [TBL] [Abstract][Full Text] [Related]
10. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants. Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299 [TBL] [Abstract][Full Text] [Related]
11. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice. Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052 [TBL] [Abstract][Full Text] [Related]
12. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection. Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS J Biol Chem; 2021; 296():100759. PubMed ID: 33965375 [TBL] [Abstract][Full Text] [Related]
13. Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection. Huang KY; Lin MS; Kuo TC; Chen CL; Lin CC; Chou YC; Chao TL; Pang YH; Kao HC; Huang RS; Lin S; Chang SY; Yang PC EMBO Mol Med; 2021 Jan; 13(1):e12828. PubMed ID: 33159417 [TBL] [Abstract][Full Text] [Related]